The Adverse Outcome Pathway for Skin Sensitisation Initiated by Covalent Binding to Proteins

This document describes the state of knowledge of the adverse outcome pathway (AOP) for skin sensitisation initiated by covalent binding to proteins, assesses the weight-of-evidence supporting the AOP, identifies the key events, and identifies databases containing test results related to those key events. AOPs can be incorporated into chemical categories-based assessments or integrated approaches for testing and assessment.


03 Sept 2014 105 pages English 9789264221444 (PDF)

Author(s): OECD